KORRO BIO, INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.99 USD | +7.40% |
|
-3.18% | +27.25% |
| 04-24 | Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing | MT |
| 04-24 | Korro Bio Insider Bought Shares Worth $999,992, According to a Recent SEC Filing | MT |
Chart calendar Korro Bio, Inc.
3.YDE2XBaiA4h1OUBjuZ4-DkcP0pAzQDdBZaDxNH3W1qg.U38HLy-Rc9wjCB8V_qxPVxREvud6BVQqMtqEfS65r_widHwsUchU7kQPBQ~020e63020ce5e98f06f444a4225d7763
Upcoming events on Korro Bio, Inc.
Past events on Korro Bio, Inc.
| 2024-04-15 | Piper Sandler Spring Biopharma Symposium |
| 2024-04-08 13:30 | Needham Healthcare Conference |
| 2024-03-26 16:01 | Q4 2023 Earnings Release |
| 2024-03-04 14:10 | TD Cowen Health Care Conference |
| 2024-01-09 14:15 | JPMorgan Healthcare Conference |
| 2023-11-02 | Annual General Meeting - M&A Vote |
| 2023-08-10 16:01 | Q2 2023 Earnings Release |
| 2023-07-14 08:30 | Korro Bio and Frequency Therapeutics Inc Merger Call |
| 2023-05-17 | Q1 2023 Earnings Release (Projected) |
| 2023-03-13 08:00 | Oppenheimer Healthcare Conference |
| 2023-03-10 07:30 | Q4 2022 Earnings Release |
| 2023-03-08 12:50 | Cowen Health Care Conference |
| 2022-12-13 08:00 | Business Update Call |
| 2022-11-20 | Q3 2022 Earnings Release (Projected) |
| 2022-09-14 12:50 | Baird Global Healthcare Conference |
| 2022-09-13 17:00 | American Academy of Otolaryngology Head and Neck Surgery Meeting |
| 2022-09-13 11:00 | H.C. Wainwright Global Investment Conference |
| 2022-08-09 16:05 | Interim 2022 Earnings Release |
| 2022-06-21 09:00 | Annual General Meeting |
| 2022-05-24 07:00 | H.C. Wainwright Global Life Sciences Investment Conference |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -84,5 -73,9 -14.46% | -85,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -58,0 | -81,1 -73,7 -10.12% | -83,6 |
|
Net income Million USD | Released Forecast Spread | -58,0 | -81,2 -74,3 -9.3% | -83,6 |
|
EPS USD | Released Forecast Spread | 0,00 | -53,1 -12,0 -340.86% | -9,54 |
| Announcement Date | 27/07/23 | 26/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -26,9 -22,3 -20.67% | -21,0 | -21,8 | -22,0 | -22,3 | -21,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -25,4 -18,2 -39.63% | -20,0 | -20,8 | -21,2 | -21,6 | -21,0 |
|
Net income Million USD | Released Forecast Spread | -25,4 -18,2 -39.78% | -20,0 | -20,8 | -21,2 | -21,6 | -21,0 |
|
EPS USD | Released Forecast Spread | -43,1 -2,36 -1723.7% | -2,51 | -2,57 | -2,63 | -2,69 | -2,66 |
| Announcement Date | 26/03/24 | - | - | - | - | - |
More events
Past sector events for Korro Bio, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- KRRO Stock
- Calendar Korro Bio, Inc.
